NanoViricides (NYSE:NNVC) Stock Crosses Below 200-Day Moving Average – Here’s Why

NanoViricides, Inc. (NYSE:NNVC)’s stock price crossed below its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $1.30 and traded as low as $1.2101. NanoViricides shares last traded at $1.23, with a volume of 171,037 shares traded.

NanoViricides Trading Down 8.9%

The business’s 50 day moving average price is $1.34 and its two-hundred day moving average price is $1.30. The stock has a market cap of $31.40 million, a P/E ratio of -1.71 and a beta of 1.82.

Institutional Trading of NanoViricides

Several large investors have recently bought and sold shares of the company. Connective Capital Management LLC purchased a new position in shares of NanoViricides during the 2nd quarter worth approximately $256,000. BlackRock Inc. bought a new position in shares of NanoViricides in the 2nd quarter worth approximately $219,000. Miller Financial Services LLC raised its position in shares of NanoViricides by 19.6% in the 3rd quarter. Miller Financial Services LLC now owns 134,000 shares of the company’s stock worth $174,000 after acquiring an additional 22,000 shares in the last quarter. Finally, Empowered Funds LLC bought a new position in shares of NanoViricides in the 3rd quarter worth approximately $46,000. 10.30% of the stock is owned by institutional investors.

NanoViricides Company Profile

NanoViricides, Inc. (NYSE American: NNVC) is a biotechnology company focused on developing broad-spectrum antiviral therapeutics. Its proprietary nanoviricide platform is designed to create nanomedicines that mimic the cellular receptors used by viruses, with the goal of binding to viral particles, disabling them and facilitating their removal from the body. The company has developed drug candidates targeting a range of viral diseases, including herpesvirus infections such as shingles and other conditions for which existing treatments may be limited.